Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

Suspected Bone & Soft Tissue Cancer

Checked: 04-03-2019 by katy.kearley Next Review: 09-01-2020

Soft Tissue Sarcoma - Overview

Patients with suspected soft tissue sarcoma should be referred to the Bristol Sarcoma Service for investigation and management at Southmead Hospital. This can be done via e-Referral using the 2ww Sarcoma function.

For non-2WW referrals to sarcoma clinic a direct email should be sent - see 2WW section of service guide for details or see below:

NON-2ww Sarcoma (e.g Schwannoma) NO NBT Email FAO Adriana - MDM Coordinator 0117 414 0532 0117 414 9455
Email referral proforma and any attachments that you may think the MDT team will find useful, e.g.: referral letters


Patients with suspected bone sarcoma should be referred to the Oxford Bone Sarcoma Service. See relevant section below.

Referral - Soft Tissue Sarcoma Service

Please use the Suspected Sarcoma 2WW Referral Form. 

At time of referral please issue the relevant patient information leaflet as below:

NBT's 2WW Patient Information Leaflet 

Bone Sarcoma - Overview

The adult bone sarcoma service for BNSSG patients is provided by the Oxford Sarcoma Service based at Nuffield Orthopaedic Centre in Oxford and accepts referrals for adult patients aged 16 years and over who meet the Two Week Wait criteria.

The service offers consultation with diagnostics and onward referral for treatment as required.

Referrals can now be made through e-Referral under the '2WW Bone' clinic type. Contact details for the Oxford Sarcoma Service can be found by accessing their website.


For children with suspected sarcoma please see Suspected Cancer - Children and Young People Sarcoma.


Referral - Bone Sarcoma

Please use the Suspected Bone Sarcoma 2WW Referral Form. for referrals into this service. As much detail as possible should be included with the referral and can be typed into the free text section of the form or added as a separate letter.

Nice Guidelines

Refer to the NICE cancer guidelines 2015 for Sarcoma.